1. Multiplexed single-cell profiling of post-perturbation transcriptional responses to define cancer vulnerabilities and therapeutic mechanism of action
- Author
-
Francisca Vazquez, Kathryn Geiger-Schuller, Danielle Dionne, Tsukasa Shibue, Samantha Bender, Todd R. Golub, Aviad Tsherniak, Andrew Jones, Orit Rozenblatt-Rosen, Andrew J. Aguirre, Mahmoud Ghandi, Brenton R. Paolella, James M. McFarland, Aviv Regev, Brian M. Wolpin, Allison Warren, Jennifer Roth, Emily Chambers, Michael V. Rothberg, Itay Tirosh, and Olena Kuksenko
- Subjects
0303 health sciences ,Cell ,Computational biology ,Biology ,Marker gene ,Phenotype ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,Mechanism of action ,030220 oncology & carcinogenesis ,Cancer cell ,medicine ,SNP ,Multiplex ,Viability assay ,medicine.symptom ,030304 developmental biology - Abstract
Assays to study cancer cell responses to pharmacologic or genetic perturbations are typically restricted to using simple phenotypic readouts such as proliferation rate or the expression of a marker gene. Information-rich assays, such as gene-expression profiling, are generally not amenable to efficient profiling of a given perturbation across multiple cellular contexts. Here, we developed MIX-Seq, a method for multiplexed transcriptional profiling of post-perturbation responses across a mixture of samples with single-cell resolution, using SNP-based computational demultiplexing of single-cell RNA-sequencing data. We show that MIX-Seq can be used to profile responses to chemical or genetic perturbations across pools of 100 or more cancer cell lines, and combine it with Cell Hashing to further multiplex additional experimental conditions, such as multiple post-treatment time points or drug doses. Analyzing the high-content readout of scRNA-seq reveals both shared and context-specific transcriptional response components that can identify drug mechanism of action and can be used to predict long-term cell viability from short-term transcriptional responses to treatment.
- Published
- 2019
- Full Text
- View/download PDF